RE:RE:RE:RE:Interesting Agreed, the company seems to be all over the map, and honestly, I find it amazing that they cannot provide a timely update on FDA and HC. Even if its to say they are still in active discussions with both agencies. Obviously a timeline would be unrealistic, however an update regarding if further testing is required or additional data is still outstanding would be reassuring for the market. I don't think that is asking too much from the company. Time is ticking for 2022, probably 2 weeks before holiday shutdown. The more silent they are, the more downward the pressure will be on the sp, especially during yr end tax loss selling.